Risk factors for early death in neonates with Down syndrome and transient leukaemia - PubMed (original) (raw)
Risk factors for early death in neonates with Down syndrome and transient leukaemia
Hideki Muramatsu et al. Br J Haematol. 2008 Aug.
Free article
Abstract
Transient leukaemia (TL) in neonates with Down syndrome (DS) is characterized by the transient appearance of blast cells in the peripheral blood that resolves spontaneously. Some TL patients die at an early age due to organ failure. Seventy DS patients with TL were studied retrospectively to identify clinical and laboratory characteristics associated with early death (<6 months of age). Sixteen of 70 patients (22.9%) died early. The main causes of death were organ failure, particularly hepatic and cardiopulmonary failure. On univariate analysis, early gestational age (EGA), high white blood cell (WBC) count (> or =100 x 10(9)/l), percentage of peripheral blasts, elevated aspartate transaminase (AST), elevated direct bilirubin (DB), and low Apgar score were significantly associated with poor survival. On multivariate analysis, EGA, WBC count, and DB were independent predictors of poor outcome. A simple risk stratification system combining EGA and WBC count was devised to predict poor outcome. Term infants (EGA > or = 37 weeks) whose WBC count was lower than 100 x 10(9)/l had the best outcome [7.7% (3/39) died early], while preterm infants (EGA < 37 weeks) whose WBC count was higher than 100 x 10(9)/l had the worst outcome [54.5% (6/11) died early]. This stratification system may be useful for identifying high-risk patients who need early therapeutic interventions.
Similar articles
- Transient leukemia (transient myeloproliferative disorder, transient abnormal myelopoiesis) of Down syndrome.
Brink DS. Brink DS. Adv Anat Pathol. 2006 Sep;13(5):256-62. doi: 10.1097/01.pap.0000213039.93328.44. Adv Anat Pathol. 2006. PMID: 16998319 Review. - Transient leukemia in newborns with Down syndrome.
Massey GV. Massey GV. Pediatr Blood Cancer. 2005 Jan;44(1):29-32. doi: 10.1002/pbc.20141. Pediatr Blood Cancer. 2005. PMID: 15558701 Review. - Acute lymphoblastic leukemia and Down syndrome: presenting features and treatment outcome in the experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP).
Arico M, Ziino O, Valsecchi MG, Cazzaniga G, Baronci C, Messina C, Pession A, Santoro N, Basso G, Conter V; Italian Association of Pediatric Hematology and Oncology (AIEOP). Arico M, et al. Cancer. 2008 Aug 1;113(3):515-21. doi: 10.1002/cncr.23587. Cancer. 2008. PMID: 18521927 - Outcome of hyperleukocytic adult acute myeloid leukaemia: a single-center retrospective study and review of literature.
Marbello L, Ricci F, Nosari AM, Turrini M, Nador G, Nichelatti M, Tedeschi A, Vismara E, Morra E. Marbello L, et al. Leuk Res. 2008 Aug;32(8):1221-7. doi: 10.1016/j.leukres.2008.01.004. Epub 2008 Mar 3. Leuk Res. 2008. PMID: 18313749 Review. - A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children's Oncology Group (COG) study POG-9481.
Massey GV, Zipursky A, Chang MN, Doyle JJ, Nasim S, Taub JW, Ravindranath Y, Dahl G, Weinstein HJ; Children's Oncology Group (COG). Massey GV, et al. Blood. 2006 Jun 15;107(12):4606-13. doi: 10.1182/blood-2005-06-2448. Epub 2006 Feb 9. Blood. 2006. PMID: 16469874 Clinical Trial.
Cited by
- Down syndrome-associated leukaemias: current evidence and challenges.
Mason NR, Cahill H, Diamond Y, McCleary K, Kotecha RS, Marshall GM, Mateos MK. Mason NR, et al. Ther Adv Hematol. 2024 Jul 23;15:20406207241257901. doi: 10.1177/20406207241257901. eCollection 2024. Ther Adv Hematol. 2024. PMID: 39050114 Free PMC article. Review. - Cytokine profiling in 128 patients with transient abnormal myelopoiesis: a report from the JPLSG TAM-10 trial.
Yamato G, Tsumura Y, Muramatsu H, Shimada A, Imaizumi T, Tsukagoshi H, Kaburagi T, Shiba N, Yamada Y, Deguchi T, Kawai T, Terui K, Ito E, Watanabe K, Hayashi Y. Yamato G, et al. Blood Adv. 2024 Jun 25;8(12):3120-3129. doi: 10.1182/bloodadvances.2023011628. Blood Adv. 2024. PMID: 38691583 Free PMC article. Clinical Trial. - Transient abnormal myelopoiesis with extramedullary involvement in a down syndrome preemie leading to an unresponsive course despite chemotherapy.
Geetha SD, Singh R, Shaham M, Cohen N, Sticco K. Geetha SD, et al. Leuk Res Rep. 2023 Jul 20;20:100381. doi: 10.1016/j.lrr.2023.100381. eCollection 2023. Leuk Res Rep. 2023. PMID: 37560406 Free PMC article. - Clinical and biological aspects of myeloid leukemia in Down syndrome.
Boucher AC, Caldwell KJ, Crispino JD, Flerlage JE. Boucher AC, et al. Leukemia. 2021 Dec;35(12):3352-3360. doi: 10.1038/s41375-021-01414-y. Epub 2021 Sep 13. Leukemia. 2021. PMID: 34518645 Free PMC article. Review. - The Mutational Landscape of Myeloid Leukaemia in Down Syndrome.
de Castro CPM, Cadefau M, Cuartero S. de Castro CPM, et al. Cancers (Basel). 2021 Aug 18;13(16):4144. doi: 10.3390/cancers13164144. Cancers (Basel). 2021. PMID: 34439298 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous